-
Mashup Score: 10Post-Procedural Anticoagulation After Primary PCI for STEMI - American College of Cardiology - 8 month(s) ago
Amit Saha, MD
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 9RIGHT: Low-Dose Anticoagulation Post Primary PCI Shows No Benefit in STEMI Patients - American College of Cardiology - 8 month(s) ago
Anticoagulation following primary PCI did not prevent adverse outcomes in patients with STEMI, according to results from the RIGHT trial presented at ESC Congress 2023. A total of 2,989 patients with STEMI undergoing primary PCI at 53 centers in China were randomized to receive placebo (n=1495) or low-dose post-procedural anticoagulation (PPA) consisting of enoxaparin, unfractionated heparin, or bivalirudin (n=1,494) for at least 48 hours. The mean age of participants was 60.9 years, 20.7% were women,
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Anticoagulation following primary #PCI did not prevent adverse outcomes in patients with #STEMI, according to findings from the RIGHT trial presented at #ESCCongress. More: https://t.co/GTg6tceP5N https://t.co/uA0lQUSUDV
-
-
Mashup Score: 7MULTivessel Immediate versus STAged RevaScularization in Acute Myocardial Infarction - American College of Cardiology - 8 month(s) ago
Dharam J. Kumbhani, MD, SM, FACC
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
📝 Trial Summary: The MULTISTARS AMI trial showed that immediate #PCI is superior to staged PCI among hemodynamically stable patients presenting with #STEMI & w/ evidence of at least 1 other nonculprit vessel that was amenable to PCI. More 👉 https://t.co/mWa198QkLu https://t.co/2bjNcgY4xG
-
-
Mashup Score: 3MULTISTARS AMI: Immediate vs. Staged Multivessel PCI in STEMI Patients - American College of Cardiology - 8 month(s) ago
Immediate multivessel PCI was non-inferior to staged multivessel PCI for reducing death and ischemic events in patients with STEMI and multivessel coronary artery disease, according to results from the MULTISTARS AMI trial presented at ESC Congress 2023. Researchers randomized 840 patients with acute STEMI and multivessel coronary artery disease from 37 sites in Europe to either immediate PCI or staged PCI of non-culprit lesions within 19-45 days. The average age of participants as 65 years and approximate
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Results from MULTISTARS AMI trial find immediate multivessel #PCI is non-inferior to staged multivessel PCI for reducing death and ischemic events in #STEMI patients and multivessel coronary artery disease. Learn more: https://t.co/cgWIevd3Hb #ESCCongress #cvCAD https://t.co/Es3QCRyIRJ
-
-
Mashup Score: 11Expedited Transfer to a Cardiac Arrest Center for Non-ST-Elevation Out-of-Hospital Cardiac Arrest - American College of Cardiology - 8 month(s) ago
Amit Saha, MD
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Pts w/o #STEMI, expedited transfer to a cardiac arrest center after resuscitated OHCA was not associated with decreased 30-day mortality compared w/ standard of care according to the ARREST trial from #ESCCongress 2023. 📝 Trial Summary: https://t.co/QPTVdhaOtY #SCA https://t.co/cHSASxckEm
-
-
Mashup Score: 43
Guidelines evaluate and summarize available evidence with the aim of assisting health professionals in proposing the best diagnostic or therapeutic approach for
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ehj_ed: Acute coronary syndromes: 2023 ESC Guidelines for the management are out https://t.co/Y2ezDH8KYK #ACS #MI #STEMI #NSTEMI #ESCCo…
-
-
Mashup Score: 6Primary Percutaneous Coronary Intervention in Patients With Spontaneous Coronary Artery Dissection vs Coronary Artery Disease: - 8 month(s) ago
Abstract Background Spontaneous coronary artery dissection (SCAD) is a rare cause of acute myocardial infarction. Revascularization in SCAD remains very challenging and therefore is not recommended…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
🔬 New #JACCINT study alert! #SCAD vs #CAD in #STEMI: 🏥👩⚕️ SCAD PPCI is on par w/ non-SCAD PPCI: 🫀in-hospital death (5.7% vs 4.8%) 🫀30-day readmission (3% vs 3.3%) 📎 https://t.co/SOc52YNtbT #CardioTwitter #PCI #cvCAD @FJ_Elola https://t.co/GNsrELZoJL
-
-
Mashup Score: 1In Certain SCAD Patients With STEMI, Primary PCI May Be Beneficial - 8 month(s) ago
A retrospective analysis of Spanish data suggests that, with proper selection, conservative management isn’t the only option.
Source: www.tctmd.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
For some SCAD patients with #STEMI, primary #PCI could be beneficial. These findings were published in #JACCINT. Read more in @TCTMD with @TCTMD_Caitlin: https://t.co/6zvicymnyO
-
-
Mashup Score: 20
Abstract. Convergent experimental and clinical evidence have established the pathophysiological importance of pro-inflammatory pathways in coronary artery disea
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
INFLAMACIÓN EN INFARTO AGUDO DE MIOCARDIO Revisión @ESC_Journals 👌🏼 - Lo bueno⏩️reparación y defensa - Lo malo⏩️Riesgo residual inflamatorio - Lo feo⏩️Explosión inflamatoria temprana #STEMI #FOAMed https://t.co/vW20lFXfqd https://t.co/F4oNZKhW4W
-
-
Mashup Score: 26Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review - 8 month(s) ago
Abstract Invasive cardiac interventions are recommended to treat ST-segment elevation myocardial infarction, non–ST-segment elevation acute coronary syndromes, multivessel coronary disease, severe …
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
A rational evidence-based approach to invasive cardiac interventions is important in patients with active, advanced cancer. Learn more in #JACCCardioOnc: https://t.co/Nc1g5KRvUe #DAPT #STEMI #epICD #CardioOnc #CardioTwitter #MedTwitter https://t.co/rbNG2QonuB
-
In pts w/#STEMI in primary #PCI while anticoag w/bivalirudin, RIGHT trial showed routine post-PCI anticoag w/ bivalirudin, enoxaparin or unfractionated heparin 🚫 assoc. w/⬇️ 30-day mortality, nonfatal stroke/MI, stent thrombosis, or ❗ revasc https://t.co/KXDeHW3rqn #ESCCongress https://t.co/N10As0ppZV